Kivitz et al. Phase 2 RCT Dazodalibep (non-antibody biologic antagonist of CD40L) in csDMARD/bDMARD-IR RA. Improve DAS28-CRP, CDAI, SDAI, TJC, SJC at day 113. @RheumNow #ACR22 Abstr#2008 https://t.co/RwRbeFC4rt https://t.co/F8bEI1lZGM
Links:
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Mechanistic Insight an…
https://acrabstracts.org/abstract/a-phase-2-randomized-double-blind-placebo-con…
14-11-2022